| BGCBX | TRCLX | BGCBX / TRCLX | |
| Total Expense Ratio | 0.96 | 1.03 | 93% |
| Annual Report Gross Expense Ratio | 8.56 | 1.73 | 495% |
| Fund Existence | 5 years | 7 years | - |
| Gain YTD | -2.609 | 20.000 | -13% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 500000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.72M | 104M | 3% |
| Annual Yield % from dividends | 0.94 | 1.36 | 69% |
| Returns for 1 year | 10.43 | 42.90 | 24% |
| Returns for 3 years | 24.09 | 56.44 | 43% |
| Returns for 5 years | -23.49 | 3.04 | -772% |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ISFIX | 20.37 | 0.19 | +0.94% |
| VY® Columbia Contrarian Core I | |||
| GSBUX | 28.60 | -0.01 | -0.03% |
| Goldman Sachs Income Builder R6 | |||
| EPSRX | 29.06 | -0.05 | -0.17% |
| NYLI Epoch Global Equity Yield Class R6 | |||
| MVCHX | 34.28 | -0.10 | -0.29% |
| MFS Mid Cap Value R3 | |||
| DRLAX | 9.94 | -0.08 | -0.80% |
| BNY Mellon Developed Markets RE Scs - A | |||